Drug Trial Radar · NCT06365216
ALS Phase II Study of NX210c
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
83
Actual
Start
Oct 25, 2024
Primary completion
Dec 29, 2025
Study completion Sep 8, 2026
Sponsor
- Lead sponsor
- Axoltis PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- ACT4ALS network
- First posted
- Apr 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will investigate the efficacy, safety, tolerability and pharmacokinetics (PK) of multiple intravenous infusions of NX210c, at two dose levels, in patients with Amyotrophic lateral sclerosis (ALS).
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
NX210cDrug
3 times a week, for 4 weeks
PlaceboDrug
3 times a week, for 4 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- The effect of NX210c on blood neurofilament light chain (NfL) or on a blood and cerebrospinal fluid (CSF) biomarker of BBB integrity.Time frame: From predose to 6-week follow-up
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Centre Hospitalier Universitaire d'Angers
Angers, France
Centre Hospitalier Universitaire De Bordeaux
Bordeaux, France
CHU de Lyon HCL
Bron, France
Centre Hospitalier Universitaire de Clermont-Ferrand - Hôpital Gabriel Montpied
Clermont-Ferrand, France
Centre Hospitalier Universitaire de Lille
Lille, France
Centre Hospitalier Et Universitaire de Limoges
Limoges, France
Centre Hospitalier Universitaire de Montpellier
Montpellier, France
Centre Hospitalier Universitaire de Nantes - Hôpital Nord Laennec
Nantes, France
Centre Hospitalier Universitaire de Nice
Nice, France
Hôpital de la Pitié Salpêtrière
Paris, France
Centre Hospitalier Universitaire de Rennes
Rennes, France
Centre Hospitalier Regional Universitaire de Tours
Tours, France
Centre Hospitalier Regional Et Universitaire De Brest
Brest, France, France
Centre Hospitalier Universitaire De Caen Normandie
Caen, France, France
Hôpital La Timone - APHM
Marseille, France, France
CHRU De Nancy
Nancy, France, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.